334 results on '"Stefanescu, Horia"'
Search Results
2. An Interdisciplinary Approach to Alcohol Use Disorders: What Hepatologists Can Do in a Resource-Limited Setting
3. Beta-Blockers Lower First Decompensation in Patients With Cirrhosis and Enduring Portal Hypertension After Etiological Treatment
4. Lactobacillus rhamnosus probiotic treatment modulates gut and liver inflammatory pathways in a hepatocellular carcinoma murine model. A preliminary study
5. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis
6. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis
7. Individual and population screening of varices needing treatment by a simple, safe and accurate test
8. The threat of carbapenem resistance in Eastern Europe in patients with decompensated cirrhosis admitted to intensive care unit
9. Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease
10. Comparison of screening strategies with two new tests to score and diagnose varices needing treatment
11. FAST and Agile–the MASLD drift: Validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent caucasian origin
12. Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology
13. An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study
14. Towards Building a Computerized System for Modelling Advanced HCC Tumors, in Order to Assist Their Minimum Invasive Surgical Treatment
15. Performance of Liver and Spleen Stiffness Measurements in Predicting Postoperative Hepatic Decompensation After HCC Resection
16. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
17. Development and prognostic relevance of a histologic grading and staging system for alcohol-related liver disease
18. Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment
19. Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study
20. The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease
21. Multiparametric ultrasound evaluation of liver fibrosis, steatosis, and viscosity in patients with chronic liver disease
22. Regression of portal hypertension: underlying mechanisms and therapeutic strategies
23. Are presepsin and resistin better markers for bacterial infection in patients with decompensated liver cirrhosis?
24. Spleen stiffness to liver stiffness ratio significantly differs between ALD and HCV and predicts disease-specific complications
25. TIPS with a Twist – The Real Life Management of a Case of Budd-Chiarirelated Acute Liver and Subsequent Multiple Organ Failure
26. Towards Building a Computerized System for Modelling Advanced HCC Tumors, in Order to Assist Their Minimum Invasive Surgical Treatment
27. Validation of NIAAAm-CRP criteria to predict alcohol-associated steatohepatitis on liver histology
28. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis
29. P- 40 PENTOXIFYLLINE USE IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS ADMITTED WITH ACUTE KIDNEY INJURY COULD DECREASE SURVIVAL: A GLOBAL STUDY
30. P-19 CHARACTERIZATION, PROGNOSTIC FACTORS, AND SURVIVAL IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS: A MULTICENTER STUDY
31. Progression of cirrhosis is not associated with clinically significant alterations in hemostasis assessed by thromboelastography
32. Validation of the Lille 4 score on a cohort of romanian severe alcoholic hepatitis patients
33. When is the optimal time to collect baseline data for calculating the Lille score in severe alcoholic hepatitis?
34. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with advanced chronic liver disease: an individual patient meta-analysis
35. Ultrasound predictors of hemodynamic TIPS dysfunction: friends or foes?
36. Recently validated non-invasive tests for liver fibrosis assessment have great performance in identifying NASH patients at risk for decompensation
37. Enhanced diagnosis and prognosis of severe alcoholic hepatitis using novel metabolomic biomarkers
38. O-25 ASSESSMENT OF MODELS FOR PREDICTING RESPONSE TO CORTICOIDS TREATMENT IN ALCOHOL-ASSOCIATED HEPATITIS: A GLOBAL COHORT STUDY
39. Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients
40. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis
41. Serum tests, liver stiffness and artificial neural networks for diagnosing cirrhosis and portal hypertension
42. Is Fasting Good When One Is at Risk of Liver Cancer?
43. Trusting your gut-a new direction in multikinase inhibitors therapy in hepatocellular carcinoma
44. Is Fasting Good When One Is at Risk of Liver Cancer?
45. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease
46. Bidimensional shear wave ultrasound elastography with supersonic imaging to predict presence of oesophageal varices in cirrhosis
47. Mechanistic Insights in Hemophagocytic Lymphohistiocytosis: Subsequent Acute Hepatic Failure in a Multiple Myeloma Patient following Therapy with Ixazomib-Lenalidomide-Dexamethasone
48. WED-332 FASTand Agile-the MASLD Drift: validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven MASLD patients of prevalent caucasian origin
49. WED-232-YI Diagnostic accuracy of two-dimensional shear wave elastography (2D-SWE) for non-invasive assessment of liver fibrosis in biopsy-proven metabolic dysfunction-associated steatotic liver disease (MASLD). Systematic-review and multi-level random effects model meta-analysis
50. SAT-525 Revolutionizing post-surgical outcome predictions: non-invasive tests and AI for hepatocellular carcinoma patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.